Cambrian Biopharma

Cambrian Biopharma is a distributed drug discovery company. It brings together scientists working in several fields related to aging diseases with experienced company builders. Thanks to advances in science, aging is better understood at the molecular, cellular, and tissue level. The new health imperative is not only to increase the healthy lifespan but to slow biological aging and thereby reduce the incidence of age-related diseases. Cambrian has several therapeutics with the potential to treat and prevent diseases in the pre-clinical development phase. By building a diversified portfolio of different companies and academic projects, Cambrian wants to exploit economies of scale, and hedge the clinical development risk by streamlining the R&D process from the inception of a project.
Cambrian Biopharma- Verve Ventures portfolio
Founders / Management Christian Angermayer, James Peyer
Sectors Health & Bio, BioTech & Pharma
Located in New York
Co-Investors SALT, Future Ventures, Apeiron, Korify Capital
Follow On

LinkedIn

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.